Study: Watch Southeast Asia Flu Origins For Vaccine Development
This article was originally published in PharmAsia News
Executive Summary
A newly published study traced the deadliest influenza viruses to Asia, which tends to develop epidemics that feed on each other to spread. The researchers reported in the journal Science suggests drug makers may be able to develop vaccines that match the latest strains of the flu. Researchers said weather patterns and travel among East and Southeast Asian nations lead to overlapping flu epidemics, eventually reaching other continents six to nine months later. Better surveillance of flu strains circulating in Asia could lead to more specific vaccines, the report suggests. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.